查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1596771

結構生物學和分子建模技術市場：按工具和應用分類 - 全球預測 2025-2030

Structural Biology & Molecular Modeling Techniques Market by Tools (Databases, SaaS & Standalone Modeling, Visualization & Analysis), Application (Drug Development, Drug Discovery) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年結構生物學和分子建模技術市場價值為93.9億美元，預計2024年將達到111億美元，複合年成長率為18.34%，到2030年將達到305.2億美元。

結構生物學和分子建模對於在原子層面上理解生物過程至關重要，為藥物發現研發、基因研究和生物技術提供重要見解。我們使用 X光結晶結構分析、核磁共振波譜和冷凍電子顯微鏡等先進技術來視覺化聚合物的結構，並使用分子動力學模擬和同源建模等計算科學方法來了解分子的行為。這些技術對於製藥主要企業的藥物設計和最佳化、學術機構的綜合生物學研究以及生物技術公司的新型治療策略的開發至關重要。

主要市場統計
基準年[2023] 93.9億美元
預測年份 [2024] 111億美元
預測年份 [2030] 305.2億美元
複合年成長率（%） 18.34%

結構生物學和分子建模市場主要是由對標靶治療和個人化醫療的需求不斷成長、需要先進研究方法的疾病日益複雜以及成像和計算技術的技術進步所推動的。潛在的機會包括用於預測建模的人工智慧和機器學習的整合、用於增強資料共用和協作的雲端基礎的工具的擴展，以及需要詳細結構分析的生技藥品和生物學名藥的成長。然而，設備高成本、資料解釋複雜以及對高技能人員的需求等挑戰可能會限制市場成長。

創新機會比比皆是，包括開發具有成本效益的技術、自動化資料處理和分析管道，以及擴大農業生物技術和環境科學等非製藥領域的應用。該市場的特點是快速發展，需要不斷適應和投資研發才能保持競爭力。對公司的建議包括優先考慮戰略夥伴關係、專注於縮小技能差距的培訓計劃以及投資於能夠滿足不斷變化的科學需求的可擴展技術。儘管存在這些障礙，創新治療方法設計中分子建模的範圍正在擴大，並且在現代實驗室中至關重要，為成長和發展開闢了廣闊的前景。

市場動態：快速發展的結構生物學和分子建模技術市場的關鍵市場洞察

結構生物學和分子建模技術市場正因供需的動態交互作用而轉變。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 由於獲得性抗藥性導致慢性病增加
    • 由於高藥物損耗率和藥物開發的後期臨床試驗導致需求增加
    • 透過使用預測軟體降低藥物失敗的可能性
  • 市場限制因素
    • 低度開發國家設備高成本且缺乏足夠的設備
  • 市場機會
    • 透過開發有效識別新先導化合物的數學模型進行新技術創新
    • 透過生物醫學研究增加最佳化藥物發現流程的研發
  • 市場挑戰
    • 缺乏熟練的專業人員

波特的五力：駕馭結構生物學與分子建模技術市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解外部對結構生物學和分子建模技術市場的影響

外部宏觀環境因素在塑造結構生物學和分子建模技術市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解結構生物學/分子建模技術市場的競爭狀況

結構生物學和分子建模技術市場的詳細市場佔有率分析提供了對供應商績效的全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的見解，以應對日益激烈的競爭。

FPNV定位矩陣結構生物學與分子建模技術市場供應商績效評估

FPNV定位矩陣是評估結構生物學和分子建模技術市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議，以規劃結構生物學和分子建模技術市場的成功之路

對於旨在加強在全球市場的影響力的公司來說，結構生物學和分子建模技術市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 慢性病發生率增加和抗藥性獲得
      • 由於藥物開發和後期臨床試驗中藥物停藥率較高，需求不斷增加。
      • 使用預測軟體可降低藥物失敗的可能性
    • 抑制因素
      • 開發中國家的設備相對昂貴且缺乏足夠的設施
    • 機會
      • 透過開發經過檢驗的數學模型來識別新的線索進行新的創新
      • 透過生物醫學研究最佳化藥物發現過程的進展
    • 任務
      • 缺乏熟練的專業人員
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章按工具分類的結構生物學與分子建模技術市場

  • 資料庫
  • SaaS 與獨立建模
    • 抗體
    • 同源建模
    • 混合
    • 分子動力學
    • 線
  • 視覺化和分析

第7章結構生物學與分子建模技術市場：依應用分類

  • 藥物開發
  • 藥物發現

第8章北美和南美結構生物學和分子建模技術市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太地區結構生物學與分子建模技術市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲、中東和非洲的結構生物學和分子建模技術市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Acellera Ltd.
  • Agilent Technologies, Inc.
  • Biomax Informatics AG
  • Bruker Corporation
  • Chemical Computing Group ULC
  • Dassault Systemes
  • Illumina, Inc.
  • Thermo Fisher Scientific Inc.
Product Code: MRR-AD36CD8984FF

The Structural Biology & Molecular Modeling Techniques Market was valued at USD 9.39 billion in 2023, expected to reach USD 11.10 billion in 2024, and is projected to grow at a CAGR of 18.34%, to USD 30.52 billion by 2030.

Structural biology and molecular modeling are pivotal to understanding biological processes at an atomic level, offering vital insights for drug discovery and development, genetic research, and biotechnology. The scope encompasses the use of advanced techniques such as X-ray crystallography, NMR spectroscopy, and cryo-electron microscopy for visualizing macromolecular structures, complemented by computational methods like molecular dynamics simulations and homology modeling to predict molecular behavior and interactions. These techniques are crucial for pharmaceutical companies in drug design and lead optimization, academic institutions for comprehensive biological research, and biotech firms for developing novel therapeutic strategies.

KEY MARKET STATISTICS
Base Year [2023] USD 9.39 billion
Estimated Year [2024] USD 11.10 billion
Forecast Year [2030] USD 30.52 billion
CAGR (%) 18.34%

The market for structural biology and molecular modeling is primarily driven by the increasing demand for targeted therapies and personalized medicine, the complexity of diseases necessitating advanced research approaches, and technological advancements in imaging and computational techniques. Potential opportunities lie in the integration of AI and machine learning for predictive modeling, expansion of cloud-based tools for enhanced data sharing and collaboration, and the growth of biologics and biosimilars demanding detailed structural analysis. However, challenges like high costs of equipment, the complexity of data interpretation, and the need for highly skilled personnel can restrict market growth.

Innovation opportunities are abundant in developing cost-effective technologies, automating data processing and analysis pipelines, and expanding applications in non-pharmaceutical sectors such as agricultural biotechnology and environmental sciences. The market is characterized by rapid advancements requiring continuous adaptation and investment in R&D to maintain competitiveness. Recommendations for businesses include prioritizing strategic partnerships, focusing on training programs to bridge the skill gap, and investing in scalable technologies that can cater to evolving scientific needs. Despite the barriers, the expanding scope of molecular modeling in innovative therapeutic design and its indispensability in modern research laboratories present substantial prospects for growth and development.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Structural Biology & Molecular Modeling Techniques Market

The Structural Biology & Molecular Modeling Techniques Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing incidences of chronic diseases coupled with acquired drug resistance property
    • Increasing demand attributed to high drug attrition rate and late-phase clinical trials in drug development
    • Reduced probability of drug failure with use of prediction software
  • Market Restraints
    • Relatively high cost of the equipment and lack of sufficient facilities in underdeveloped countries
  • Market Opportunities
    • Emerging technological innovations with the development of validated mathematical models for identification of novel leads
    • Increasing developments in optimization of drug discovery process with biomedical research
  • Market Challenges
    • Dearth of skilled professional

Porter's Five Forces: A Strategic Tool for Navigating the Structural Biology & Molecular Modeling Techniques Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Structural Biology & Molecular Modeling Techniques Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Structural Biology & Molecular Modeling Techniques Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Structural Biology & Molecular Modeling Techniques Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Structural Biology & Molecular Modeling Techniques Market

A detailed market share analysis in the Structural Biology & Molecular Modeling Techniques Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Structural Biology & Molecular Modeling Techniques Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Structural Biology & Molecular Modeling Techniques Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Structural Biology & Molecular Modeling Techniques Market

A strategic analysis of the Structural Biology & Molecular Modeling Techniques Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Structural Biology & Molecular Modeling Techniques Market, highlighting leading vendors and their innovative profiles. These include Acellera Ltd., Agilent Technologies, Inc., Biomax Informatics AG, Bruker Corporation, Chemical Computing Group ULC, Dassault Systemes, Illumina, Inc., and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Structural Biology & Molecular Modeling Techniques Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Tools, market is studied across Databases, SaaS & Standalone Modeling, and Visualization & Analysis. The SaaS & Standalone Modeling is further studied across Antibodies, Homology Modeling, Hybrid, Molecular Dynamics, and Threading.
  • Based on Application, market is studied across Drug Development and Drug Discovery.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing incidences of chronic diseases coupled with acquired drug resistance property
      • 5.1.1.2. Increasing demand attributed to high drug attrition rate and late-phase clinical trials in drug development
      • 5.1.1.3. Reduced probability of drug failure with use of prediction software
    • 5.1.2. Restraints
      • 5.1.2.1. Relatively high cost of the equipment and lack of sufficient facilities in underdeveloped countries
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging technological innovations with the development of validated mathematical models for identification of novel leads
      • 5.1.3.2. Increasing developments in optimization of drug discovery process with biomedical research
    • 5.1.4. Challenges
      • 5.1.4.1. Dearth of skilled professional
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Structural Biology & Molecular Modeling Techniques Market, by Tools

  • 6.1. Introduction
  • 6.2. Databases
  • 6.3. SaaS & Standalone Modeling
    • 6.3.1. Antibodies
    • 6.3.2. Homology Modeling
    • 6.3.3. Hybrid
    • 6.3.4. Molecular Dynamics
    • 6.3.5. Threading
  • 6.4. Visualization & Analysis

7. Structural Biology & Molecular Modeling Techniques Market, by Application

  • 7.1. Introduction
  • 7.2. Drug Development
  • 7.3. Drug Discovery

8. Americas Structural Biology & Molecular Modeling Techniques Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Structural Biology & Molecular Modeling Techniques Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Structural Biology & Molecular Modeling Techniques Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Acellera Ltd.
  • 2. Agilent Technologies, Inc.
  • 3. Biomax Informatics AG
  • 4. Bruker Corporation
  • 5. Chemical Computing Group ULC
  • 6. Dassault Systemes
  • 7. Illumina, Inc.
  • 8. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET RESEARCH PROCESS
  • FIGURE 2. STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET DYNAMICS
  • TABLE 7. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY DATABASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY HOMOLOGY MODELING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY HYBRID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY MOLECULAR DYNAMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY THREADING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY VISUALIZATION & ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY DRUG DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAAS & STANDALONE MODELING, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 148. STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET, FPNV POSITIONING MATRIX, 2023